Accessing investment capital by listing on the London Stock Exchange (LSE) is the aim of CBD products firm South West Brands (SWB). Described as “the first multi-brand CBD-focused consumer goods business to list on the LSE” in an announcement by SWB, the group wants to take advantage of the current investor appetite for CBD businesses.
“Our listing on the LSE will enable SWB to access the new pool of cannabis investors that has grown in London following the successful admission of a number of cannabis companies in 2021,” explains SWB’s CEO Rebekah Hall. “The admission will allow the group to advance to the next stages of its growth plans, and build a suite of strong brands that not only utilise CBD, but drive consumer engagement and product sell-through, something which has been missing in the industry thus far.”
Institutional funds and investor clients of brokers Arden Partners are being targeted for the fundraise, conditional on admission to the LSE.
SWB reports that it is following the final procedures for admission to the LSE, expecting completion in the coming month. There is a proposal to raise equity, through placing new ordinary shares, to fund the development and expansion of its existing portfolio of brand IP assets. The group develops, licenses and markets CBD brands to consumers across the UK, and had identified key product areas and markets to target. These are drinks, menstrual cycle care, ‘generation z’ skincare, sport, men’s holistic wellness, menopausal care and 50+ supplements.
SWB’s website lists one available brand, Botanic Lab, which includes a CBD soft drink, and two “coming spring/summer 2021”, Fewe and Love MeMeMe.